Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5184978
Max Phase: Preclinical
Molecular Formula: C28H38N6O4S2
Molecular Weight: 586.78
Associated Items:
ID: ALA5184978
Max Phase: Preclinical
Molecular Formula: C28H38N6O4S2
Molecular Weight: 586.78
Associated Items:
Canonical SMILES: COc1ccc(S(N)(=O)=O)cc1C(=O)N[C@@H](CCN1[C@@H]2CC[C@H]1C[C@H](n1c(C)nnc1C(C)C)C2)c1cccs1
Standard InChI: InChI=1S/C28H38N6O4S2/c1-17(2)27-32-31-18(3)34(27)21-14-19-7-8-20(15-21)33(19)12-11-24(26-6-5-13-39-26)30-28(35)23-16-22(40(29,36)37)9-10-25(23)38-4/h5-6,9-10,13,16-17,19-21,24H,7-8,11-12,14-15H2,1-4H3,(H,30,35)(H2,29,36,37)/t19-,20+,21-,24-/m0/s1
Standard InChI Key: URSXJUUUKXUXFY-XARGGIHNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 586.78 | Molecular Weight (Monoisotopic): 586.2396 | AlogP: 4.16 | #Rotatable Bonds: 10 |
Polar Surface Area: 132.44 | Molecular Species: BASE | HBA: 9 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 10.26 | CX Basic pKa: 8.96 | CX LogP: 2.03 | CX LogD: 0.65 |
Aromatic Rings: 3 | Heavy Atoms: 40 | QED Weighted: 0.36 | Np Likeness Score: -1.53 |
1. Xie X, Zheng YG, Chen H, Li J, Luo RH, Chen L, Zheng CB, Zhang S, Peng P, Ma D, Yang LM, Zheng YT, Liu H, Wang J.. (2022) Structure-Based Design of Tropane Derivatives as a Novel Series of CCR5 Antagonists with Broad-Spectrum Anti-HIV-1 Activities and Improved Oral Bioavailability., 65 (24.0): [PMID:36472561] [10.1021/acs.jmedchem.2c01383] |
Source(1):